BEONE MEDICINES LTD. (BEIGF) Gross margin 2016–2025
BEONE MEDICINES LTD. (BEIGF) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.5%FY2025 · since FY2016: 100.0% → 87.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.5% | +3.1 pp |
| FY2024 | 84.4% | -0.1 pp |
| FY2023 | 84.5% | +4.8 pp |
| FY2022 | 79.8% | -6.2 pp |
| FY2021 | 86.0% | +8.9 pp |
| FY2020 | 77.1% | -6.3 pp |
| FY2019 | 83.4% | -2.1 pp |
| FY2018 | 85.5% | -12.4 pp |
| FY2017 | 97.9% | -2.1 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice